Annual Total Debt
$657.71 K
-$107.55 K-14.05%
31 December 2023
Summary:
Sunshine Biopharma annual total debt is currently $657.71 thousand, with the most recent change of -$107.55 thousand (-14.05%) on 31 December 2023. During the last 3 years, it has fallen by -$1.26 million (-65.62%). SBFMW annual total debt is now -65.62% below its all-time high of $1.91 million, reached on 31 December 2020.SBFMW Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$556.55 K
-$20.81 K-3.60%
30 September 2024
Summary:
Sunshine Biopharma quarterly total debt is currently $556.55 thousand, with the most recent change of -$20.81 thousand (-3.60%) on 30 September 2024. Over the past year, it has dropped by -$116.98 thousand (-17.37%). SBFMW quarterly total debt is now -86.98% below its all-time high of $4.27 million, reached on 31 December 2022.SBFMW Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.1% | -17.4% |
| 3 y3 years | -65.6% | -84.3% |
| 5 y5 years | -31.0% | -26.0% |
SBFMW Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.6% | at low | -87.0% | at low |
| 5 y | 5 years | -65.6% | at low | -87.0% | at low |
| alltime | all time | -65.6% | -87.0% |
Sunshine Biopharma Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $556.55 K(-3.6%) |
| June 2024 | - | $577.36 K(-5.7%) |
| Mar 2024 | - | $612.37 K(-6.9%) |
| Dec 2023 | $657.71 K(-14.1%) | $657.71 K(-2.3%) |
| Sept 2023 | - | $673.53 K(-6.3%) |
| June 2023 | - | $719.00 K(-2.1%) |
| Mar 2023 | - | $734.44 K(-82.8%) |
| Dec 2022 | $765.26 K(-59.7%) | $4.27 M(+125.0%) |
| Dec 2021 | $1.90 M(-0.7%) | $1.90 M(-46.2%) |
| Sept 2021 | - | $3.53 M(+39.8%) |
| June 2021 | - | $2.53 M(-7.8%) |
| Mar 2021 | - | $2.74 M(+43.4%) |
| Dec 2020 | $1.91 M(+167.4%) | $1.91 M(+88.3%) |
| Sept 2020 | - | $1.02 M(+61.0%) |
| June 2020 | - | $631.00 K(-1.7%) |
| Mar 2020 | - | $641.68 K(-10.3%) |
| Dec 2019 | $715.57 K(-24.9%) | $715.57 K(-4.8%) |
| Sept 2019 | - | $751.67 K(-3.5%) |
| June 2019 | - | $778.78 K(-37.2%) |
| Mar 2019 | - | $1.24 M(+30.1%) |
| Dec 2018 | $952.60 K(+18.7%) | $952.60 K(+4.6%) |
| Sept 2018 | - | $910.56 K(-28.5%) |
| June 2018 | - | $1.27 M(-6.9%) |
| Mar 2018 | - | $1.37 M(+70.5%) |
| Dec 2017 | $802.32 K(+238.6%) | $802.32 K(+35.6%) |
| Sept 2017 | - | $591.75 K(+46.3%) |
| June 2017 | - | $404.49 K(+58.4%) |
| Mar 2017 | - | $255.33 K(+7.7%) |
| Dec 2016 | $236.97 K(-79.2%) | $236.97 K(-4.8%) |
| Sept 2016 | - | $248.99 K(-23.2%) |
| June 2016 | - | $324.14 K(-70.7%) |
| Mar 2016 | - | $1.10 M(-3.2%) |
| Dec 2015 | $1.14 M | $1.14 M(+172.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $418.64 K(+7.2%) |
| June 2015 | - | $390.64 K(+24.8%) |
| Mar 2015 | - | $313.13 K(-34.8%) |
| Dec 2014 | $480.12 K(+3741.0%) | $480.12 K(+21.2%) |
| Sept 2014 | - | $396.00 K(+40.2%) |
| June 2014 | - | $282.50 K(+113.2%) |
| Mar 2014 | - | $132.50 K(+960.0%) |
| Dec 2013 | $12.50 K(-80.0%) | $12.50 K(0.0%) |
| Sept 2013 | - | $12.50 K(0.0%) |
| June 2013 | - | $12.50 K(0.0%) |
| Mar 2013 | - | $12.50 K(-80.0%) |
| Dec 2012 | $62.50 K(>+9900.0%) | $62.50 K(+400.0%) |
| Sept 2012 | - | $12.50 K(0.0%) |
| June 2012 | - | $12.50 K(0.0%) |
| Mar 2012 | - | $12.50 K(>+9900.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | - |
| Oct 2009 | - | $0.00(-100.0%) |
| July 2009 | - | $31.00 K(+17.0%) |
| Apr 2009 | - | $26.50 K(+20.5%) |
| Jan 2009 | - | $22.00 K(0.0%) |
| Oct 2008 | - | $22.00 K(+29.4%) |
| July 2008 | $17.00 K(>+9900.0%) | $17.00 K(+25.9%) |
| Apr 2008 | - | $13.50 K(>+9900.0%) |
| Jan 2008 | - | $0.00(0.0%) |
| Oct 2007 | - | $0.00 |
| July 2007 | $0.00 | - |
FAQ
- What is Sunshine Biopharma annual total debt?
- What is the all time high annual total debt for Sunshine Biopharma?
- What is Sunshine Biopharma annual total debt year-on-year change?
- What is Sunshine Biopharma quarterly total debt?
- What is the all time high quarterly total debt for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly total debt year-on-year change?
What is Sunshine Biopharma annual total debt?
The current annual total debt of SBFMW is $657.71 K
What is the all time high annual total debt for Sunshine Biopharma?
Sunshine Biopharma all-time high annual total debt is $1.91 M
What is Sunshine Biopharma annual total debt year-on-year change?
Over the past year, SBFMW annual total debt has changed by -$107.55 K (-14.05%)
What is Sunshine Biopharma quarterly total debt?
The current quarterly total debt of SBFMW is $556.55 K
What is the all time high quarterly total debt for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly total debt is $4.27 M
What is Sunshine Biopharma quarterly total debt year-on-year change?
Over the past year, SBFMW quarterly total debt has changed by -$116.98 K (-17.37%)